Last reviewed · How we verify
NCT00151931
Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving Dialysis
Phase 3 trial testing Lanthanum carbonate in Kidney Failure, Chronic in 456 participants. Completed in 12 January 2006.
12 January 2006
Quick facts
| Lead sponsor | Shire |
|---|---|
| Phase | Phase 3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 456 |
| Start date | 11 May 2004 |
| Primary completion | 12 January 2006 |
| Estimated completion | 12 January 2006 |
Drugs / interventions tested
- Lanthanum carbonate — full drug profile →
Conditions studied
- Kidney Failure, Chronic — all drugs for Kidney Failure, Chronic →
Sponsor
Shire — full company profile →
Who can join
18 and older, any sex, with Kidney Failure, Chronic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to assess phosphate reduction and control in patients with End Stage Renal Disease treated with lanthanum carbonate
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT00151931
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lanthanum carbonate
Trials testing the same drug.
- NCT02209636 — Phosphate Lowering in CKD Trial · Phase 4 · completed
- NCT01128179 — Effects of Lanthanum Carbonate on FGF-23 in Subjects With Stage 3 CKD · Phase 2 · completed
- NCT01130831 — Effect of Lanthanum Carbonate in Patients Previously Treated With Calcium-based Phosphate Binder Therapy · completed
- NCT00452478 — Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5 · Phase 4 · terminated
- NCT00557323 — Long-term Effect of Lanthanum Carbonate on Bone · completed
Other recruiting trials for Kidney Failure, Chronic
Currently open trials in the same condition.
- NCT06903559 — Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis Patients · Phase 1, PHASE2 · recruiting
- NCT06438445 — Effects of Royal Jelly Supplementation in Chronic Kidney Disease · NA · recruiting
- NCT06288451 — DePTH: De-emphasize PTH · Phase 2 · active not recruiting
- NCT05968391 — Acetoacetate and Acetate Metabolism in Patients With Chronic Kidney Failure.(RENO-TEP) · recruiting
- NCT06314503 — First-in-human Study to Examine Safety of a New Peritoneal Dialysis Device (WEAKID) in End-stage Kidney Disease Patients · NA · recruiting
Other Shire trials
Trials by the same sponsor.
- NCT05067868 — A Study of Replagal in Children and Adults With Fabry Disease in India · Phase 4 · recruiting
- NCT03878953 — A Clinical Study of rhPTH(1-84) Treatment in Japanese Participants With Chronic Hypoparathyroidism · Phase 3 · withdrawn
- NCT04840667 — A Study of Replagal in Treatment-naïve Adults With Fabry Disease · Phase 3 · terminated
- NCT04429984 — Post Marketing Surveillance (PMS) Study for Velaglucerase Alfa (VPRIV) in India · completed
- NCT04440488 — ARALAST NP Alpha-1 Lung Density Chronic Obstructive Pulmonary Disease-Emphysema (COPD-E) Study · Phase 4 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00151931 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shire
- Last refreshed: 8 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00151931.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing